Silence Therapeutics plc Accrued Liabilities and Other Liabilities
Silence Therapeutics plc (SLN) had Accrued Liabilities and Other Liabilities of $5.75 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-03-05
- 2025-12-31: Accrued Liabilities and Other Liabilities $5.75M.
- 2024-12-31: Accrued Liabilities and Other Liabilities $8.36M.
- 2023-12-31: Accrued Liabilities and Other Liabilities $7.85M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2025-12-31 | $5.75M 10-K · filed 2026-03-05 |
| 2024-12-31 | $8.36M 10-K · filed 2026-03-05 |
| 2023-12-31 | $7.85M 10-K · filed 2025-02-27 |